Disseminated Intravascular Coagulation in Pregnancy

Key Points

• Obstetric DIC is a rare but life-threatening secondary coagulopathy that can occur antepartum, intrapartum, or postpartum.
• Pathology involves uncontrolled clot formation and fibrinolysis, causing both microvascular thrombosis and severe bleeding from factor/platelet consumption.
• Early bedside cues include oozing from puncture sites and unexplained hematuria in high-risk obstetric contexts.
• DIC diagnosis is trend-based, not a single-test diagnosis, and pregnancy-adjusted baseline interpretation is essential.
• Initial management priorities are trigger-cause control, perfusion/oxygen support, and balanced blood-component replacement.
• Massive transfusion often uses PRBC:plasma:platelet replacement with fibrinogen support (for example cryoprecipitate).

Pathophysiology

In pregnancy-associated DIC, an underlying obstetric trigger causes diffuse activation of coagulation pathways. Widespread microthrombi consume platelets and coagulation factors while fibrinolysis also accelerates, producing simultaneous clotting and hemorrhage risk.

As factor depletion progresses, bleeding can become massive and refractory. Organ injury may develop from combined hypoperfusion, microvascular occlusion, and hemorrhagic shock physiology.

Classification

• Trigger-associated obstetric DIC: Secondary to placental abruption, postpartum hemorrhage, amniotic fluid embolism, preeclampsia/HELLP-spectrum disease, sepsis, or fetal demise.
• Consumption-dominant phase: Progressive thrombocytopenia and factor depletion with rising bleeding risk.
• Organ-hypoperfusion phase: Microvascular thrombosis plus blood-loss shock causing multi-organ dysfunction.

Nursing Assessment

NCLEX Focus

In obstetric DIC, trend change from pregnancy baseline can be more important than a single “normal range” result.

• Identify high-risk trigger conditions early (abruption, severe hemorrhage, embolic/infectious hypertensive complications, fetal demise).
• When AFE is suspected, anticipate abrupt shift from cardiopulmonary collapse to consumptive coagulopathy with severe hemorrhage.
• Assess for early bleeding cues: oozing from IV/needle sites and blood in urinary drainage.
• Monitor hemodynamics, oxygenation, urine output, mental status, skin perfusion, and shock progression.
• Trend CBC/coagulation studies with baseline comparison:
• PT/INR and aPTT prolongation relative to patient baseline.
• Downtrending platelets (even if still in laboratory reference range initially).
• Fibrinogen decline from baseline; severe hemorrhage concern increases markedly at very low levels (for example below 100 mg/dL).
• D-dimer elevation can occur but is less specific in pregnancy.
• Monitor temperature and acid-base status because hypothermia and acidosis worsen coagulopathy.
• During high-volume transfusion, monitor electrolytes and rhythm risk (notably hyperkalemia and hypocalcemia contexts).

Nursing Interventions

• Escalate immediately and treat the underlying trigger cause while resuscitation proceeds.
• Support airway/oxygenation and maintain perfusion with protocolized hemorrhage response.
• Prepare balanced blood-component replacement and fibrinogen support (for example cryoprecipitate) per provider protocol.
• Anticipate target-oriented correction in severe cases (for example hemoglobin around 7 g/dL or higher, fibrinogen around 200 mg/dL or higher, platelets around 50,000/microL or higher, PT/aPTT less than 1.5 times control before urgent surgery when feasible).
• Maintain normothermia during transfusion/resuscitation and assist correction of metabolic acidosis per order.
• Prepare emergency operative pathway when maternal instability or fetal compromise requires urgent delivery.
• After acute stabilization, continue thrombosis-risk prevention planning (for example SCDs or prophylactic anticoagulation in stable postoperative/postpartum contexts).

Dual-Risk Instability

Obstetric DIC can deteriorate into catastrophic bleeding and organ thrombosis simultaneously; delayed escalation is frequently fatal.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
blood-products	PRBC, plasma, platelets, cryoprecipitate	Balanced replacement supports oxygen delivery, coagulation factors, platelet count, and fibrinogen restoration.
antifibrinolytics	TXA specialist-directed context	Use requires strict risk-benefit assessment in DIC pathways because clotting and bleeding risks coexist.

Clinical Judgment Application

Clinical Scenario

A postpartum patient with severe hemorrhage develops persistent oozing from IV sites, falling platelets, prolonged coagulation times from baseline, and worsening hypotension.

• Recognize Cues: Consumptive coagulopathy pattern with progressive shock.
• Analyze Cues: Findings suggest obstetric DIC secondary to massive hemorrhage.
• Prioritize Hypotheses: Immediate priorities are trigger control, hemodynamic stabilization, and factor/platelet replacement.
• Generate Solutions: Activate DIC-capable hemorrhage protocol, coordinated blood-component therapy, temperature and acid-base management, and surgical readiness.
• Take Action: Execute rapid multidisciplinary resuscitation and source control.
• Evaluate Outcomes: Perfusion improves, laboratory trends stabilize, and definitive obstetric management is completed safely.

Related Concepts

• postpartum-hemorrhage - Major obstetric trigger and overlap pathway for consumptive coagulopathy.
• placental-abruption - Classic high-risk trigger condition for obstetric DIC.
• obstetrical-emergencies - DIC is a core hemostatic emergency requiring rapid team activation.
• maternal-sepsis - Infectious trigger contexts can rapidly precipitate coagulopathy.
• preeclampsia - Severe preeclampsia/HELLP pathways can overlap with DIC physiology.
• hellp-syndrome - HELLP-associated thrombocytopenia and liver injury can rapidly progress into DIC physiology.
• amniotic-fluid-embolism - AFE can precipitate sudden obstetric DIC with rapid hemostatic collapse.

Self-Check

1. Why can obstetric DIC be missed if labs are interpreted without pregnancy baseline trends?
2. Which bedside finding often appears early before full laboratory collapse?
3. What are the first three simultaneous priorities once obstetric DIC is suspected?